Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Pancreatic cancer
2025 Standout
A Gram-negative-selective antibiotic that spares the gut microbiome
2024 StandoutNature
Works of Lin Shen being referenced
Nimotuzumab combined with gemcitabine versus gemcitabine in K-RAS wild-type locally advanced or metastatic pancreatic cancer: A prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial.
2022
Prevalence and impact of Clostridioides difficile infection among hospitalized patients with coranavirus disease 201 9
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Lin Shen | 320 | 137 | 198 | 445 | 253 | 97 | 1.4k | |
| Weina Li | 120 | 81 | 51 | 311 | 216 | 48 | 1.2k | |
| Jinhui Zhang | 141 | 129 | 262 | 171 | 407 | 90 | 1.5k | |
| Xiufen Wang | 76 | 67 | 112 | 243 | 313 | 99 | 1.5k | |
| Luyao Chen | 293 | 186 | 176 | 200 | 262 | 86 | 1.7k | |
| Ting Wang | 125 | 104 | 159 | 461 | 516 | 86 | 1.7k | |
| Qingming Wu | 163 | 83 | 134 | 363 | 565 | 70 | 1.4k | |
| Yu Han | 197 | 324 | 255 | 109 | 437 | 73 | 1.6k | |
| Shaowen Tang | 228 | 173 | 150 | 268 | 237 | 91 | 1.6k | |
| Alireza Zali | 146 | 125 | 229 | 389 | 244 | 176 | 1.7k | |
| Yuling Zhang | 103 | 125 | 221 | 164 | 443 | 102 | 1.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...